VEGFA and squamous cell carcinoma: In the present study, 51.4% of patients had adenocarcinoma, 34.3% had squamous cell carcinoma and 14.3% had large cell carcinoma, however, no correlation was observed between the plasma levels of VEGF 165 and the different histological subtypes (P=0.40).